UBS AM’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,600
| Closed | -$106K | – | 2704 |
|
|
2023
Q2 | $106K | Hold |
39,600
| – | – | ﹤0.01% | 2641 |
|
|
2023
Q1 | $106K | Buy |
39,600
+27,300
| +222% | +$73.2K | ﹤0.01% | 2641 |
|
|
2022
Q4 | $66.8K | Buy |
+12,300
| New | +$66.8K | ﹤0.01% | 2507 |
|
|
2022
Q2 | – | Sell |
-41,011
| Closed | -$312K | – | 2794 |
|
|
2022
Q1 | $312K | Hold |
41,011
| – | – | ﹤0.01% | 2584 |
|
|
2021
Q4 | $419K | Hold |
41,011
| – | – | ﹤0.01% | 2614 |
|
|
2021
Q3 | $550K | Hold |
41,011
| – | – | ﹤0.01% | 2463 |
|
|
2021
Q2 | $900K | Buy |
41,011
+2,899
| +8% | +$63.6K | ﹤0.01% | 2265 |
|
|
2021
Q1 | $917K | Buy |
38,112
+4,222
| +12% | +$102K | ﹤0.01% | 2132 |
|
|
2020
Q4 | $610K | Buy |
33,890
+8,647
| +34% | +$156K | ﹤0.01% | 2221 |
|
|
2020
Q3 | $292K | Buy |
25,243
+1,378
| +6% | +$15.9K | ﹤0.01% | 2310 |
|
|
2020
Q2 | $579K | Sell |
23,865
-187,248
| -89% | -$4.54M | ﹤0.01% | 2055 |
|
|
2020
Q1 | $2.33M | Sell |
211,113
-41,123
| -16% | -$453K | ﹤0.01% | 1346 |
|
|
2019
Q4 | $6.67M | Buy |
252,236
+7,840
| +3% | +$207K | ﹤0.01% | 1084 |
|
|
2019
Q3 | $5.57M | Sell |
244,396
-4,886
| -2% | -$111K | ﹤0.01% | 1164 |
|
|
2019
Q2 | $7.64M | Buy |
249,282
+113,294
| +83% | +$3.47M | 0.01% | 1042 |
|
|
2019
Q1 | $2.26M | Buy |
135,988
+711
| +0.5% | +$11.8K | ﹤0.01% | 1460 |
|
|
2018
Q4 | $2.59M | Sell |
135,277
-14,639
| -10% | -$280K | ﹤0.01% | 1322 |
|
|
2018
Q3 | $7.84M | Buy |
+149,916
| New | +$7.84M | 0.01% | 996 |
|